18
MAR
Reports
Q3, 2024 earnings report expected
CDMO
Avid Bioservices Inc.
0
0
(0%)
EPS
$-0.0525
Estimated Sales
$33.46M
Market Cap
$385.13M
CDMO
-1.25 (-10.98%)
10.10
10.15
@MarketUpdates
United Kingdom
18
MAR
Reports
Q3, 2024 earnings report expected
CDMO
Avid Bioservices Inc.
0
0
(0%)
EPS
$-0.0525
Estimated Sales
$33.46M
Market Cap
$385.13M
1 Mentioned
CDMO
Avid Bioservices Inc.